Filter Results:
(7,335)
Show Results For
- All HBS Web
(7,335)
- People (56)
- News (2,114)
- Research (3,646)
- Events (20)
- Multimedia (101)
- Faculty Publications (2,337)
Show Results For
- All HBS Web
(7,335)
- People (56)
- News (2,114)
- Research (3,646)
- Events (20)
- Multimedia (101)
- Faculty Publications (2,337)
- 17 Dec 2021
- News
Lead by Empowering Others: Lauren Collins & Frances Frei
- June 2001 (Revised May 2002)
- Case
Innovation at Progressive (C): Auto Repair
By: Frances X. Frei and Hanna Rodriguez-Farrar
Analyzes whether Progressive should enter the auto repair industry. The critical decision is whether the competencies that made Progressive succeed in the auto insurance industry can translate to the auto repair industry. View Details
Keywords: Market Entry and Exit; Innovation and Invention; Insurance Industry; Service Industry; Auto Industry
Frei, Frances X., and Hanna Rodriguez-Farrar. "Innovation at Progressive (C): Auto Repair." Harvard Business School Case 601-139, June 2001. (Revised May 2002.)
- September 2011 (Revised December 2014)
- Background Note
Learning to Negotiate
By: Michael Wheeler
This brief note introduces to the student the challenges and rewards of learning to be a more skilled negotiator. Negotiation requires the integration of keen analytic insight with emotional intelligence capabilities. View Details
Wheeler, Michael. "Learning to Negotiate." Harvard Business School Background Note 912-004, September 2011. (Revised December 2014.)
- December 2005 (Revised August 2006)
- Case
Amgen Inc.'s Epogen--Commercializing the First Biotech Blockbuster Drug
By: Felix Oberholzer-Gee and Dennis A. Yao
Amgen Inc.'s Epogen was the first biotech blockbuster drug. Epogen helped prevent anemia, a condition that leads to severe fatigue, increased risk of cardiovascular disease, and even death. At the time, the market for Epogen, which included dialysis patients and... View Details
Keywords: Health Care and Treatment; Strategic Planning; Competition; Patents; Innovation and Invention; Pharmaceutical Industry; Biotechnology Industry; United States
Oberholzer-Gee, Felix, and Dennis A. Yao. "Amgen Inc.'s Epogen--Commercializing the First Biotech Blockbuster Drug." Harvard Business School Case 706-454, December 2005. (Revised August 2006.)
- 23 Nov 2022
- News
The Myth of the Brilliant, Charismatic Leader
- 03 Dec 2008
- Working Paper Summaries
Performance Persistence in Entrepreneurship
- Video
Vimal Shah
Vimal Shah, Co-Founder and Chairman of Bidco Africa, discusses the group’s strategic approach to marketing soap products in Kenya, targeting the bottom of the pyramid market with multiple brands at different price points to compete with large multinationals such as... View Details
Ramon Casadesus-Masanell
Ramon Casadesus-Masanell is the Herman C. Krannert Professor of Business Administration at the Harvard Business School. He joined HBS in 2000 where he has taught the required MBA Strategy course, an elective course on Competing Business Models, and Ph.D. courses on... View Details
- 06 Jul 2016
- News
Verizon’s Pursuit of Yahoo Puts the Spotlight on a Rising Star
- 05 Nov 2017
- Blog Post
What You Need to Know about SVMP
The HBS Summer Venture in Management Program, an immersive, weeklong experience for rising college seniors, was developed to increase diversity and opportunity in business education. During their time on campus, SVMPers gain business... View Details
- 19 Apr 2018
- Video
SHLD Final Pitch New Venture Competition 2018 Social Enterprise Track
- Teaching Interest
The Entrepreneurial Manager
This course addresses the issues faced by managers who wish to turn opportunity into viable organizations that create value, and empowers students to develop their own approaches, guidelines, and skills for being entrepreneurial managers.
View Details- November 1991 (Revised April 1994)
- Case
Nucleon, Inc.
By: Gary P. Pisano
Nucleon is a small biotechnology company whose first potential product is about to enter clinical testing. Before Nucleon can begin clinical trials, however, its management must decide how and where to manufacture the product. Three options are being contemplated: 1)... View Details
Keywords: Factories, Labs, and Plants; Entrepreneurship; Health Testing and Trials; Rights; Product Development; Production; Partners and Partnerships; Research and Development; Biotechnology Industry
Pisano, Gary P. "Nucleon, Inc." Harvard Business School Case 692-041, November 1991. (Revised April 1994.)
- 20 Oct 2014
- Research & Ideas
Users Love Ello, But What’s the Business Model?
As yet, there is no foolproof way to monetize social capital. If there were, Ello would be well on its way to financial success. The upstart social networking site set the internet abuzz recently by introducing an ad-free platform, and... View Details
- 09 Jul 2024
- Video
Preparing for Your Finance Job Search with Wall Street Prep (CPD)
- December 1999 (Revised October 2003)
- Case
BRL Hardy: Globalizing an Australian Wine Company
Two new product launch decisions face Christopher Carson, managing director of BRL Hardy, Europe. Responsible for the European operations of a major Australian wine company, Carson has begun to globalize his strategy beyond selling the parent company's wines. After a... View Details
Keywords: Global Strategy; Joint Ventures; Product Launch; Brands and Branding; Competitive Strategy; Business Subsidiaries; Negotiation Style; Food and Beverage Industry
Bartlett, Christopher A. "BRL Hardy: Globalizing an Australian Wine Company." Harvard Business School Case 300-018, December 1999. (Revised October 2003.)
- 28 Jan 2002
- Research & Ideas
Read All About It! Newspapers Lose Web War
Many newspapers saw the emergence of the Internet as an attack on their core business, and responded with online products of their own. Unfortunately, says HBS professor Clark Gilbert, the papers failed to take advantage of the Web as a... View Details
- 01 Nov 1999
- Lessons from the Classroom
What’s Next & So What? Leading in the 21st Century
Leading in the 21st Century is an HBS Executive Education program being held in January 2000. Professors Gary Hamel and John Kotter talk about the course and the new realities of leadership View Details
Keywords: by Staff